Compare ARK Genomic Revolution ETF (ARKG) vs Synchrony Financial (SYF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Synchrony Financial — how do they compare? ARK Genomic Revolution ETF trades at $44.8, while Synchrony Financial trades at $78.6 (market cap $25.53B). The key difference: Synchrony Financial pays a 1.73% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Synchrony Financial nearer its low. Which is the better fit depends on your goals.
| ARKG | SYF | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $44.55 | $88.47 |
52-Week Low | $24.02 | $63.78 |
Market Cap | — | $25.53B |
Dividend Yield | — | 1.73% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Synchrony Financial
Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →
